Bedeutung des viszeralen Fettgewebes für das metabolische Syndrom

 

 Buy Article Permissions and Reprints

Zusammenfassung

Klinische und tierexperimentelle Untersuchungen haben gezeigt, dass das Fettverteilungsmuster das individuelle metabolische Risiko besser determiniert als die Gesamtkörperfettmasse. Es besteht eine positive Korrelation zwischen viszeraler Fettmasse und Insulinresistenz, metabolischem Syndrom, koronarem Herzkrankheits-Risiko sowie der hepatischen Glukoseproduktion. Die Beziehung zwischen Fettverteilungsmuster und Alter, Geschlecht, Energiehaushalt und mit metabolischen und genetischen Charakteristika wird diskutiert. Dabei werden Unterschiede in der Insulinsensitivität, der lipolytischen Aktivität, dem Glukosestoffwechsel und der endokrinen Regulation in Abhängigkeit von der Fettgewebslokalisation dargestellt. Die klinische Bedeutung einer differenzierten Charakterisierung der viszeral-betonten Adipositas besteht darin, Risikogruppen des Metabolischen Syndroms aufgrund molekularer und genetischer Marker der viszeralen Adipositas zu definieren und daraus Strategien zur Differenzialtherapie der Adipositas abzuleiten.

Summary

Epidemiological and animal studies often reported an association between increased visceral obesity and the prevalence of insulin resistance, type 2 diabetes, the risk of cardiovascular and cerebrovascular diseases and the hepatic glucose production. The correlation of fat distribution with age, gender energy balance and with metabolic and genetic characteristics are discussed. Especially, the differences in insulin sensitivity, lipolytic activity, glucose metabolism, and the endocrine regulation depending on the regional adipose tissue distribution are presented.

Literatur

• 1 Abate N, Garg A, Peshock R M, Stray-Gundersen J, Grundy S M. Relationships of generalized and regional adiposity to insulin sensitivity in men.  J Clin Invest. 1995;  96 88-98
  Google Scholar
• 2 Adams M, Montague C T, Prins J B. et al . Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.  J Clin Invest. 1997;  100 3149-3153
  Google Scholar
• 3 Alessi M C, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.  Diabetes. 1997;  46 860-867
  Google Scholar
• 4 Arner P, Hellstrom L, Wahrenberg H, Bronnengard M. Beta-adrenorezeptor expression in human fat cells from different regions.  J Clin Invest. 1990;  86 1595-1600
  Google Scholar
• 5 Arner P. Impact of visceral fat.  Int J Obesity. 1997;  21 (Suppl 2) S20
  Google Scholar
• 6 Barzilai N, She L, Liu B Q, Vuguin P, Cohen P, Wang J, Rossetti L. Surgical removal of visceral fat reverses hepatic insulin resistance.  Diabetes. 1999;  48 94-98
  Google Scholar
• 7 Björntorp P. The regulation of adipose tissue distribution in humans.  Int J Obesity. 1996;  20 291-302
  Google Scholar
• 8 Blüher M, Michael M D, Peroni O D, Ueki K, Carter N, Kahn B B, Kahn C R. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance.  Dev Cell. 2002;  3 25-38
  Google Scholar
• 9 Bouchard C, Tremblay A, Depres J P. et al . The response to long-term overfeeding in identical twins.  N Engl J Med. 1990;  322 1477-1482
  Google Scholar
• 10 Bouchard C, Despres J -P, Mariege P O. Genetic and nongenetic determinants of regional fat distribution.  Endocr Rev. 1993;  14 72-93
  Google Scholar
• 11 Bouchard C, Tremblay A, Depres J P. et al . The response to exercise with constant energy intake in identical twins.  Obes Res. 1997;  2 400-410
  Google Scholar
• 12 Comuzzie A, Allison D. The search for human obesity genes.  Science. 1998;  280 1374-1377
  Google Scholar
• 13 Despres J P, Nadeau A, Tremblay A. et al . Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women.  Diabetes. 1989;  38 304-309
  Google Scholar
• 14 Dieudonne M N, Pecquery R, Boumediene A, Leneveu M C, Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids.  Am J Physiol. 1998;  274 C1645-1652
  Google Scholar
• 15 Donahue R P, Abbott R D, Bloom E, Reed D M, Yano K. Central obesity and coronary heart disease in men.  Lancet. 1987;  1 821-824
  Google Scholar
• 16 Engeli S, Feldpausch M, Gorzelniak K. et al . Association Between Adiponectin and Mediators of Inflammation in Obese Women.  Diabetes. 2003;  52 942-947
  Google Scholar
• 17 Ferrannini E, Barrett E J, Bevilacqua S, DeFronzo R A. Effect of fatty acids on glucose production and utilization in man.  J Clin Invest. 1983;  72 1737-1747
  Google Scholar
• 18 Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity.  J Clin Invest. 1997;  100 1166-1173
  Google Scholar
• 19 Frayn K N. Visceral fat and insulin resistance - causative or correlative?.  Br J Nutr. 2000;  83 S71-S77
  Google Scholar
• 20 Fried S K, Bunkin D A, Greenberg A S. Omental and subcutaneous adipose tissue of obese sunjects release interleukin 6: depot difference and regulation by glucocorticoid.  J Clin Endocrinol Metab. 1998;  83 847-850
  Google Scholar
• 21 Goodpaster B H, Thaete F L, Simoneau J A, Kelley D E. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.  Diabetes. 1997;  46 1579-1585
  Google Scholar
• 22 Hauner H, Wabitsch M, Pfeiffer E F. Differentiation of adipocyte precursor cells from obese and nonobese adult women and from different adipose tissue sites.  Horm Metab Res Suppl. 1988;  19 35-39
  Google Scholar
• 23 Hellmer J, Marcus C, Sonnenfeld T, Arner P. Mechanisms for differences in lipolysis between human fat cells from different regions.  J Clin Endocrinol Metab. 1992;  75 15-20
  Google Scholar
• 24 Kannel W B. Lipids, diabetes and coronary heart disease: insights from the Framingham Study.  Am Heart J. 1985;  110 1100-1107
  Google Scholar
• 25 Kelly I E, Han T S, Walsh K, Lean M E. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes.  Diabetes Care. 1999;  22 288-293
  Google Scholar
• 26 King H, Aubert R E, Hermann W H. Global burden of diabetes, 1995 - 2025: prevalence, numerical estimates, and projections.  Diabetes Care. 1998;  21 1414-1431
  Google Scholar
• 27 Kopf D, Lehnert H. Predictive examinations of phenotypically healthy offspring of patients with a metabolic syndrome.  Dtsch Med Wochenschr. 2001;  126 235-240
  Google Scholar
• 28 Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913.  Br Med J. 1984;  288 1401-1404
  Google Scholar
• 29 Lefebvre A M, Laville M, Vega N, Riou J P, van Gaal L, Auwerx J, Vidal H. Depot-specific differences in adipose tissue gene expression in lean and obese subjects.  Diabetes. 1998;  47 98-103
  Google Scholar
• 30 Lemieux S, Depres J P, Moorjani S. et al . Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue?.  Diabetologia. 1994;  37 757-764
  Google Scholar
• 31 Massi-Benedetti M. CODE-2 Advisory Board. The cost of diabetes Type II in Europe: the CODE-2 Study.  Diabetologia. 2002;  45 S1-4
  Google Scholar
• 32 Montague C T, O`Rahilly S. The perils of portliness: Causes and consequences of visceral adiposity.  Diabetes. 2000;  49 883-888
  Google Scholar
• 33 Montague C T, Prins J B, Sanders L. et al . Depot-related gene expression in human subcutaneous and omental adipocytes.  Diabetes. 1998;  47 1384-1391
  Google Scholar
• 34 Pedersen S B, Hansen P S, Lund S, Andersen P H, Odgaard A, Richelsen B. Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue.  Eur J Clin Invest. 1996;  26 262-269
  Google Scholar
• 35 Perusse L, Chagnon Y C, Weisnagel J, Bouchard C. The human obesity gene map: the 1998 update.  Obes Res. 1999;  7 111-129
  Google Scholar
• 36 Pouliot M -C, Despres J -P, Lemieux S. et al . Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.  Am J Cardiol. 1994;  73 460-468
  Google Scholar
• 37 Reaven G M. Role of insulin resistance in human disease.  Diabetes. 1998;  37 1595-1607
  Google Scholar
• 38 Rebuffe-Scrive M, Lundholm K, Bjorntorp P. Glucocorticoid hormone binding to human adipse tissue.  Eur J Clin Invrest. 1985;  15 267-271
  Google Scholar
• 39 Rice T, Despres J -P, Daw E W. et al . Familial resemblance for abdominal visceral fat: the HERITAGE Family Study.  Int J Obes. 1997;  21 1024-1031
  Google Scholar
• 40 Ross R, Leger L, Morris D, de Guisse J, Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables.  J Appl Physiol. 1992;  72 787-795
  Google Scholar
• 41 Seidell J C, Oosterlee A, Deurenberg P, Hautavast J G, Ruijs J H. Abdominal fat depots measured by computed tomography: effects of degree of obesity, sex and age.  Eur J Clin Nutr. 1988;  54 471-477
  Google Scholar
• 42 Smith S R, Lovejoy J C, Greenway F. et al . Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.  Metabolism. 2001;  50 425-435
  Google Scholar
• 43 Smith S R, Zachwieja J J. Visceral adipose tissue: a critical review of intervention strategies.  Int J Obes. 1999;  23 329-335
  Google Scholar
• 44 Staiger H, Tschritter O, Machann J. et al . Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans.  Obes Res. 2003;  11 368-372
  Google Scholar
• 45 Thomas E L, Saed N, Hajnal J V, Brynes A, Goldstone A P, Frost G, Bell J D. Magnetic resonance imaging of total body fat.  J Applied Phys. 1998;  85 1778-1785
  Google Scholar
• 46 Vague J. The degree of masculine differentiation of obesities, a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease.  Am J Clin Nutr. 1956;  4 20-34
  Google Scholar
• 47 Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women.  Diabetes. 1998;  47 913-917
  Google Scholar
• 48 Vikman H L, Savola J M, Raasmaja A, Ohisalo J J. Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes.  Int J Obes Relat Metab Disord. 1996;  20 185-189
  Google Scholar
• 49 Wajchenberg B L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.  Endocrine Reviews. 2000;  21 697-738
  Google Scholar
• 50 Zierath J R, Livingston J N, Thorne A, Bolinder J, Reynisdottir S, Lonnqvist F, Arner P. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway.  Diabetologia. 1998;  41 1343-1354
  Google Scholar

Prof. Dr. med. R. Paschke

Universität Leipzig, Medizinische Klinik und Poliklinik III

Philipp-Rosenthal-Straße 27

04103 Leipzig

Phone: 0341/9713200

Fax: 0341/9713249

Email: pasr@medizin.uni-leipzig.de